Think Surgical Inc. has obtained FDA 510(k) clearance for its TMINI miniature robotic system to be used in conjunction with Medacta's GMK Sphere and SpheriKA knee systems. This clearance expands the options available for robotic-assisted total knee arthroplasty (TKA).
The collaboration between Think Surgical and Medacta, initially announced on August 29, integrates Think Surgical's robotic surgery platform with Medacta's knee implant systems. The goal is to provide surgeons and patients with more personalized solutions for total knee replacement.
"Medacta’s commitment to innovation aligns well with Think Surgical’s dedication," said Stuart Simpson, president and CEO of Think Surgical. "We are excited to partner with Medacta in the U.S. to offer customers greater ."
Matt Goudy, managing director and president of Medacta USA, stated, "This partnership marks another step forward in our commitment to offering cutting-edge technologies that drive sustainable innovation forward and enhance our ability to deliver personalized solutions for surgeons and patients worldwide."
The TMINI system is designed to assist surgeons in performing precise bone resections during TKA, potentially leading to improved implant alignment and patient outcomes. The integration with Medacta's GMK Sphere and SpheriKA knee systems offers a comprehensive solution for robotic-assisted knee replacement.
